MXPA03000051A
(es)
|
2000-06-28 |
2003-08-19 |
Smithkline Beecham Plc |
Procedimiento de molido en humedo.
|
AU2002246864A1
(en)
|
2000-12-27 |
2002-07-24 |
The Trustees Of Columbia University In The City Of New York |
Pim kinase-related methods
|
DE10123055A1
(de)
|
2001-05-11 |
2003-03-20 |
Gruenenthal Gmbh |
Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase
|
DE10226702A1
(de)
|
2002-06-14 |
2004-09-09 |
Grünenthal GmbH |
Antisense Oligonukleotide gegen PIM1
|
US20040142864A1
(en)
|
2002-09-16 |
2004-07-22 |
Plexxikon, Inc. |
Crystal structure of PIM-1 kinase
|
WO2006078228A1
(en)
|
2002-09-16 |
2006-07-27 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
US20050164300A1
(en)
|
2003-09-15 |
2005-07-28 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
WO2005033310A1
(de)
|
2003-10-01 |
2005-04-14 |
Grünenthal GmbH |
Pim-1-spezifische dsrna-verbindungen
|
WO2006006569A1
(ja)
|
2004-07-12 |
2006-01-19 |
Nihon Nohyaku Co., Ltd. |
フェニルピリジン類又はその塩類、これらを有効成分とする除草剤及びその使用方法
|
WO2006071960A2
(en)
|
2004-12-28 |
2006-07-06 |
Kinex Pharmaceuticals, Llc |
Compositions and methods of treating cell proliferation disorders
|
KR101125919B1
(ko)
|
2005-06-22 |
2012-06-12 |
플렉시콘, 인코퍼레이티드 |
단백질 키나제 억제제로서의 피롤로[2,3-b]피리딘 유도체
|
WO2007011760A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
AU2006302174B2
(en)
*
|
2005-10-06 |
2013-06-20 |
Exelixis, Inc. |
Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3
|
WO2007041712A1
(en)
|
2005-10-06 |
2007-04-12 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
AU2006304874B8
(en)
|
2005-10-21 |
2013-07-04 |
Exelixis, Inc. |
Pyrimidinones as casein kinase II (CK2) modulators
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
WO2007084857A2
(en)
|
2006-01-13 |
2007-07-26 |
President And Fellows Of Harvard College |
Methods and compositions for treating cell proliferative disorders
|
WO2007131191A2
(en)
|
2006-05-05 |
2007-11-15 |
Perkinelmer Life And Analytical Sciences |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
EP2041071B1
(en)
|
2006-06-29 |
2014-06-18 |
Kinex Pharmaceuticals, LLC |
Biaryl compositions and methods for modulating a kinase cascade
|
WO2008002676A2
(en)
|
2006-06-29 |
2008-01-03 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
JP5252404B2
(ja)
|
2006-08-16 |
2013-07-31 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ピラジン化合物、その使用及び調製方法
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
JP4968860B2
(ja)
|
2006-10-31 |
2012-07-04 |
シェーリング コーポレイション |
アニリノピペラジン誘導体およびアニリノピペラジン誘導体を使用する方法
|
BRPI0718029A2
(pt)
|
2006-11-06 |
2013-11-26 |
Supergen Inc |
Derivados de imidazo(1,2-b)piridazina e pirazolo(1,5-a)pirimidina e seu uso como inibidores da proteína cinase
|
WO2008082840A1
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
WO2008082839A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
EA019951B1
(ru)
|
2007-03-01 |
2014-07-30 |
Новартис Аг |
Ингибиторы киназы pim и способы их применения
|
CA2682231A1
(en)
|
2007-03-28 |
2008-10-09 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
CA2682981C
(en)
|
2007-04-03 |
2015-11-17 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
MX2009011578A
(es)
|
2007-04-25 |
2009-11-11 |
Exelixis Inc |
6-fenilpirimidinonas como moduladores de pim.
|
MX2009011579A
(es)
|
2007-04-25 |
2009-11-11 |
Exelixis Inc |
Pirimidinonas como moduladores de caseina cinasa ii (ck2).
|
EP2178861B1
(en)
|
2007-07-19 |
2014-08-20 |
Merck Sharp & Dohme Corp. |
Heterocyclic amide compounds as protein kinase inhibitors
|
AU2008282885A1
(en)
|
2007-07-31 |
2009-02-05 |
Schering Corporation |
Anti-mitotic agent and aurora kinase inhibitor combination as anti-cancer treatment
|
WO2009064486A2
(en)
|
2007-11-15 |
2009-05-22 |
Musc Foundation For Research Development |
Inhibitors of pim protein kinases, compositions, and methods for treating cancer
|
EP2209889B1
(en)
|
2007-11-16 |
2016-07-20 |
San Diego State University Research Foundation |
Compositions for manipulating pim-1 activity in cardiac cells
|
MX2010009445A
(es)
|
2008-02-29 |
2011-05-25 |
Cylene Pharmaceuticals Inc |
Moduladores de proteina kinasa.
|
US8168794B2
(en)
|
2008-03-03 |
2012-05-01 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
PE20091577A1
(es)
*
|
2008-03-03 |
2009-11-05 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso
|
CN102316737A
(zh)
|
2008-05-12 |
2012-01-11 |
安内斯蒂克斯公司 |
用于rho激酶抑制和改善学习与记忆的化合物
|
CN102137866A
(zh)
|
2008-06-30 |
2011-07-27 |
赛林药物股份有限公司 |
羟吲哚化合物
|
TWI461423B
(zh)
|
2008-07-02 |
2014-11-21 |
Astrazeneca Ab |
用於治療Pim激酶相關病狀及疾病之噻唑啶二酮化合物
|
FR2933409B1
(fr)
|
2008-07-03 |
2010-08-27 |
Centre Nat Rech Scient |
NOUVEAUX PYRROLO °2,3-a! CARBAZOLES ET LEUR UTILISATION COMME INHIBITEURS DES KINASES PIM
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
CA2735779A1
(en)
|
2008-09-02 |
2010-03-11 |
Matthew Burger |
Bicyclic kinase inhibitors
|
EA020136B1
(ru)
|
2008-09-02 |
2014-08-29 |
Новартис Аг |
Производные пиколинамида в качестве ингибиторов киназы
|
CN102197032B
(zh)
|
2008-09-02 |
2014-07-23 |
诺华股份有限公司 |
杂环pim-激酶抑制剂
|
PT2725028T
(pt)
|
2008-10-22 |
2016-08-31 |
Array Biopharma Inc |
Compostos de pirazolo[1,5-]pirimidina substituídos como intermediários na síntese de inibidores de cinase trk
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
WO2010071885A1
(en)
|
2008-12-19 |
2010-06-24 |
Cephalon, Inc. |
Pyrrolotriazines as alk and jak2 inhibitors
|
WO2010135401A2
(en)
|
2009-05-19 |
2010-11-25 |
San Diego State University Foundation |
Kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
|
RU2011151835A
(ru)
|
2009-05-20 |
2013-06-27 |
Сайлин Фармасьютикалс, Инк. |
Пиразолопиримидины и родственные гетероциклы как ингибиторы киназ
|
US20100298302A1
(en)
|
2009-05-20 |
2010-11-25 |
Fabrice Pierre |
Novel protein kinase modulators
|
AR076794A1
(es)
|
2009-05-22 |
2011-07-06 |
Incyte Corp |
Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen
|
WO2010148351A1
(en)
|
2009-06-18 |
2010-12-23 |
Cylene Pharmaceuticals, Inc. |
Rhodanines and related heterocycles as kinase inhibitors
|
PT2448938E
(pt)
|
2009-06-29 |
2014-07-31 |
Incyte Corp |
Pirimidinonas como inibidoras de pi3k
|
EP2470544A1
(en)
|
2009-08-26 |
2012-07-04 |
Cylene Pharmaceuticals, Inc. |
Condensed quinolines as protein kinase modulators
|
US9249145B2
(en)
|
2009-09-01 |
2016-02-02 |
Incyte Holdings Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
US8435976B2
(en)
|
2009-09-08 |
2013-05-07 |
F. Hoffmann-La Roche |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
EP2475659B1
(en)
|
2009-09-08 |
2015-10-28 |
F.Hoffmann-La Roche Ag |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
CN102625803A
(zh)
|
2009-09-11 |
2012-08-01 |
赛林药物股份有限公司 |
药学上有用的杂环-取代的内酰胺
|
SG179163A1
(en)
|
2009-09-16 |
2012-05-30 |
Cylene Pharmaceuticals Inc |
Novel tricyclic protein kinase modulators
|
EP2477495A1
(en)
|
2009-09-16 |
2012-07-25 |
Cylene Pharmaceuticals, Inc. |
Tricyclic compounds and pharmaceutical uses thereof
|
EP2493313B1
(en)
|
2009-10-29 |
2017-12-13 |
Genosco |
Kinase inhibitors
|
EP2332917B1
(en)
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
CA2780031A1
(en)
|
2009-11-12 |
2011-05-19 |
Selvita S.A. |
A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
|
KR101663637B1
(ko)
|
2009-11-13 |
2016-10-07 |
제노스코 |
키나아제 억제제
|
US8853235B2
(en)
|
2009-11-23 |
2014-10-07 |
Senhwa Biosciences, Inc. |
Polymorphs and salts of a kinase inhibitor
|
PL2509602T3
(pl)
|
2009-12-04 |
2017-08-31 |
Senhwa Biosciences, Inc. |
Pirazolopirymidyny i podobne heterocykle jako inhibitory ck2
|
WO2011075613A1
(en)
|
2009-12-18 |
2011-06-23 |
Sanofi |
Azaindole derivatives, their preparation and their therapeutic application
|
TW201130842A
(en)
|
2009-12-18 |
2011-09-16 |
Incyte Corp |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
KR101858097B1
(ko)
|
2009-12-23 |
2018-05-15 |
자스코 파머수티컬스, 엘엘씨 |
아미노피리미딘 키나제 억제제
|
GB201002861D0
(en)
|
2010-02-19 |
2010-04-07 |
Cxr Biosciences Ltd |
Compositions
|
KR101911697B1
(ko)
|
2010-03-10 |
2018-10-25 |
인사이트 홀딩스 코포레이션 |
Jak1 저해제로서의 피페리딘4일 아제티딘 유도체
|
EA201290957A1
(ru)
*
|
2010-04-07 |
2013-04-30 |
Ф.Хоффманн-Ля Рош Аг |
Пиразол-4-илгетероциклилкарбоксамидные соединения и способы их применения
|
JP5816678B2
(ja)
|
2010-04-14 |
2015-11-18 |
インサイト・コーポレイションIncyte Corporation |
PI3Kδ阻害剤としての縮合誘導体
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
WO2012004217A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
RU2604062C2
(ru)
*
|
2010-07-13 |
2016-12-10 |
Ф.Хоффманн-Ля Рош Аг |
ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНА И ТИЕНО[3,2-b]ПИРИМИДИНА В КАЧЕСТВЕ МОДУЛЯТОРОВ IRAK-4
|
SG186850A1
(en)
|
2010-07-29 |
2013-02-28 |
Rigel Pharmaceuticals Inc |
Ampk-activating heterocyclic compounds and methods for using the same
|
US8227773B2
(en)
|
2010-07-29 |
2012-07-24 |
Axcelis Technologies, Inc. |
Versatile beam glitch detection system
|
US8802099B2
(en)
|
2010-11-10 |
2014-08-12 |
National Jewish Health |
Methods to treat allergic conditions
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
JP5917544B2
(ja)
|
2010-11-19 |
2016-05-18 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン
|
NZ611151A
(en)
|
2010-11-19 |
2015-06-26 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
JP2014500277A
(ja)
|
2010-12-09 |
2014-01-09 |
アムジエン・インコーポレーテツド |
Pim阻害剤としての二環式化合物
|
CN103298816A
(zh)
|
2010-12-17 |
2013-09-11 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的取代的吡唑并-喹唑啉衍生物
|
TW201249844A
(en)
|
2010-12-20 |
2012-12-16 |
Incyte Corp |
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
|
ES2602791T3
(es)
|
2011-01-26 |
2017-02-22 |
Nerviano Medical Sciences S.R.L. |
Derivados de pirrolo tricíclicos, proceso para su preparación y su uso como inhibidores de cinasa
|
ES2586588T3
(es)
|
2011-01-26 |
2016-10-17 |
Nerviano Medical Sciences S.R.L. |
Derivados tricíclicos, procedimiento para su preparación y su uso como inhibidores de quinasa
|
CN103492377B
(zh)
|
2011-02-25 |
2016-04-20 |
阵列生物制药公司 |
作为pim激酶抑制剂的三唑并吡啶化合物
|
UY33929A
(es)
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Compuestos de ciclohexilo tetrasustituido como inhibidores de quinasas
|
UY33930A
(es)
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
JP2014510105A
(ja)
|
2011-03-22 |
2014-04-24 |
アムジエン・インコーポレーテツド |
Pim阻害剤としてのアゾール化合物
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
MX2013011612A
(es)
|
2011-04-05 |
2013-10-17 |
Pfizer Ltd |
Derivados de pirrolo[2,3-d]pirimidina como inhibidores de quinasa relacionados con tropomiosina.
|
JP5976778B2
(ja)
|
2011-04-11 |
2016-08-24 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としてのピラゾリル−ピリミジン誘導体
|
EP2699569B1
(en)
|
2011-04-22 |
2017-08-30 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
GB201107197D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Compounds
|
GB201107176D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Pyrrolnitrin derivatives
|
EP2702063A1
(en)
|
2011-04-29 |
2014-03-05 |
Amgen Inc. |
Bicyclic pyridazine compounds as pim inhibitors
|
WO2012156367A1
(en)
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
US9284334B2
(en)
|
2011-05-19 |
2016-03-15 |
Fundación Centro Nacional De Investigaciones Oncologicas Carlos Iii |
Macrocyclic compounds as protein kinase inhibitors
|
EP2714048A4
(en)
|
2011-05-27 |
2014-11-05 |
Univ Temple |
SUBSTITUTED 2-BENZYLIDENE-2H-BENZO- [B -] [1,4-] THIAZIN-3- (4H-) ONE, DERIVATIVES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF
|
EP2714692B1
(en)
|
2011-06-01 |
2017-03-22 |
Bayer Intellectual Property GmbH |
Substituted aminoimidazopyridazines
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
CN103764656A
(zh)
|
2011-06-22 |
2014-04-30 |
拜耳知识产权有限责任公司 |
杂环基氨基咪唑并哒嗪
|
US9416132B2
(en)
|
2011-07-21 |
2016-08-16 |
Tolero Pharmaceuticals, Inc. |
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors
|
CN102924445B
(zh)
|
2011-08-11 |
2015-07-08 |
上海吉铠医药科技有限公司 |
Pim激酶抑制剂及其制备方法与在制药中的应用
|
BR112014003296A2
(pt)
|
2011-08-12 |
2017-03-14 |
Hoffmann La Roche |
composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, método para o tratamento de uma doença ou distúrbio, conjunto para o tratamento de uma condição mediada pela quinase pim e utilização do composto
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
TWI673272B
(zh)
|
2011-09-02 |
2019-10-01 |
美商英塞特控股公司 |
作為pi3k抑制劑之雜環基胺
|
JP5843524B2
(ja)
|
2011-09-02 |
2016-01-13 |
キヤノン株式会社 |
有機無機複合組成物、有機無機複合材料、光学素子および積層型回折光学素子
|
UA117092C2
(uk)
|
2011-09-06 |
2018-06-25 |
Байєр Інтеллектуал Проперті Гмбх |
Амінозаміщені імідазопіридазини
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
WO2013041634A1
(en)
|
2011-09-23 |
2013-03-28 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
RU2638552C2
(ru)
|
2011-09-27 |
2017-12-14 |
Ф. Хоффманн-Ля Рош Аг |
Пиразол-4-ил-гетероциклил-карбоксамидные соединения и способы применения
|
JP6063945B2
(ja)
|
2011-10-07 |
2017-01-18 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としての4−アルキル置換3,4−ジヒドロピロロ[1,2−a]ピラジン−1(2H)−オン誘導体
|
JP5998223B2
(ja)
|
2011-10-07 |
2016-09-28 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としての置換3,4−ジヒドロピロロ[1,2−a]ピラジン−1(2H)−オン誘導体
|
CN104011046B
(zh)
|
2011-11-04 |
2017-05-03 |
嘉世高制药公司 |
氨基嘧啶激酶抑制剂
|
WO2013130660A1
(en)
|
2012-02-28 |
2013-09-06 |
Amgen Inc. |
Amides as pim inhibitors
|
EP2822944A1
(en)
|
2012-03-05 |
2015-01-14 |
Amgen, Inc. |
Oxazolidinone compounds and derivatives thereof
|
WO2013144189A1
(en)
|
2012-03-29 |
2013-10-03 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
CN104321326B
(zh)
|
2012-04-04 |
2017-05-31 |
拜耳医药股份有限公司 |
氨基取代的咪唑并哒嗪
|
UY34763A
(es)
|
2012-04-26 |
2013-10-31 |
Bristol Myers Squibb Co |
Inhibidores de la agregación plaquetaria
|
CA2870336A1
(en)
|
2012-04-27 |
2013-10-31 |
Novartis Ag |
Cyclic bridgehead ether dgat1 inhibitors
|
WO2013170068A2
(en)
|
2012-05-09 |
2013-11-14 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
HUE039138T2
(hu)
|
2012-05-15 |
2018-12-28 |
Novartis Ag |
Benzamidszármazékok ABL1, ABL2 és BCR-ABL1 aktivitás gátlására
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
JP6204462B2
(ja)
|
2012-05-21 |
2017-09-27 |
ノバルティス アーゲー |
キナーゼ阻害剤としての新規環置換n−ピリジニルアミド
|
JP6165848B2
(ja)
|
2012-05-22 |
2017-07-19 |
イデニク ファーマシューティカルズ エルエルシー |
肝疾患のためのd−アミノ酸化合物
|
TWI568722B
(zh)
|
2012-06-15 |
2017-02-01 |
葛蘭馬克製藥公司 |
作爲mPGES-1抑制劑之三唑酮化合物
|
WO2014001377A1
(en)
|
2012-06-27 |
2014-01-03 |
F. Hoffmann-La Roche Ag |
5-azaindazole compounds and methods of use
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲RORc調節劑之芳基磺內醯胺衍生物
|
TW201414737A
(zh)
|
2012-07-13 |
2014-04-16 |
必治妥美雅史谷比公司 |
作爲激酶抑制劑之咪唑并三□甲腈
|
WO2014022752A1
(en)
|
2012-08-03 |
2014-02-06 |
Amgen Inc. |
Macrocycles as pim inhibitors
|
WO2014033630A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Novel aminothiazole carboxamides as kinase inhibitors
|
WO2014033631A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
N-(3-pyridyl) biarylamides as kinase inhibitors
|
CN103664878A
(zh)
|
2012-09-12 |
2014-03-26 |
山东亨利医药科技有限责任公司 |
杂芳环及其衍生物类酪氨酸激酶抑制剂
|
EP2895485A1
(en)
|
2012-09-14 |
2015-07-22 |
AbbVie Deutschland GmbH & Co. KG |
Tricyclic quinoline and quinoxaline derivatives
|
UA119229C2
(uk)
|
2012-09-26 |
2019-05-27 |
Ф. Хоффманн-Ля Рош Аг |
Циклічні ефіри піразол-4-ілгетероциклілкарбоксамідних сполук та способи їх застосування
|
WO2014053568A1
(en)
|
2012-10-02 |
2014-04-10 |
Sanofi |
Indolyldihydroimidazopyrimidinone derivatives, preparation thereof and therapeutic use thereof
|
PE20150723A1
(es)
|
2012-10-16 |
2015-05-15 |
Janssen Sciences Ireland Uc |
Compuestos antiviricos para el vsr
|
UA117572C2
(uk)
|
2012-11-01 |
2018-08-27 |
Інсайт Холдинґс Корпорейшн |
Трициклічні конденсовані похідні тіофену як інгібітори jak
|
HK1208025A1
(en)
|
2012-11-19 |
2016-02-19 |
拜耳医药股份公司 |
Aminoimidazopyridazines
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
SI3418281T1
(sl)
*
|
2012-12-07 |
2021-02-26 |
Vertex Pharmaceuticals Inc. |
Pirazolo(1,5-A)pirimidini, uporabni kot zaviralci kinaze ATR za zdravljenje rakavih obolenj
|
DK2935302T3
(en)
|
2012-12-18 |
2018-08-13 |
Vertex Pharma |
MANNOS DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
|
ES2715682T3
(es)
|
2012-12-19 |
2019-06-05 |
Novartis Ag |
Inhibidores de la autotaxina
|
US20150336960A1
(en)
|
2012-12-19 |
2015-11-26 |
Novartis Ag |
Aryl-substituted fused bicyclic pyridazine compounds
|
UY35213A
(es)
|
2012-12-21 |
2014-06-30 |
Gilead Sciences Inc |
Compuestos del tipo de las carbamilpiridonas policíclicas y su uso farmaceutico
|
MY199894A
(en)
|
2012-12-21 |
2023-11-27 |
Epizyme Inc |
Prmt5 inhibitors and uses thereof
|
FR3000569B1
(fr)
|
2013-01-03 |
2015-02-13 |
Peugeot Citroen Automobiles Sa |
Dispositif d'eclairage a ecran a bord(s) lumineux
|
ES2649156T3
(es)
|
2013-01-14 |
2018-01-10 |
Incyte Holdings Corporation |
Compuestos bicíclicos de carboxamida aromática útiles como inhibidores de quinasas Pim
|
SG10201705662WA
(en)
|
2013-01-15 |
2017-08-30 |
Incyte Corp |
Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
|
TWI687220B
(zh)
|
2013-03-01 |
2020-03-11 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
BR112015021458B1
(pt)
|
2013-03-06 |
2022-06-07 |
Incyte Holdings Corporation |
"processos e intermediários para preparar {1-{1-[3-flúor2-(trifluormetil)isonicotinoil] piperidin-4-il}-3-[4-(7hpirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]azetidin-3-il}acetonitrila, útil no tratamento de doenças relacionadas com a atividade de janus quinases
|
JO3383B1
(ar)
|
2013-03-14 |
2019-03-13 |
Lilly Co Eli |
مثبطات cdc7
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
SG11201507227UA
(en)
|
2013-03-15 |
2015-10-29 |
Actelion Pharmaceuticals Ltd |
Pyridin-4-yl derivatives
|
ES2890077T3
(es)
|
2013-03-15 |
2022-01-17 |
Global Blood Therapeutics Inc |
Compuestos y usos de los mismos para la modulación de la hemoglobina
|
WO2014145051A1
(en)
|
2013-03-15 |
2014-09-18 |
Jiazhong Zhang |
Heterocyclic compounds and uses thereof
|
US20160052926A1
(en)
|
2013-03-15 |
2016-02-25 |
Hutchison Medipharma Limited |
Novel pyrimidine and pyridine compounds and usage thereof
|
EP3640249A1
(en)
|
2013-03-15 |
2020-04-22 |
Dow AgroSciences LLC |
4-amino-6-(heterocyclic)picolinates and 6-amino-2-(heterocyclic)pyrimidine-4-carboxylates and their use as herbicides
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
AU2014237330A1
(en)
|
2013-03-15 |
2015-09-17 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
SG11201506924YA
(en)
|
2013-03-15 |
2015-09-29 |
Incyte Corp |
Tricyclic heterocycles as bet protein inhibitors
|
SI2975028T1
(en)
|
2013-03-15 |
2018-07-31 |
Japan Tobacco, Inc. |
PIRAZOL-AMIDIC COMPOUNDS AND MEDICINAL USE FORM
|
UY35421A
(es)
|
2013-03-15 |
2014-10-31 |
Nihon Nohyaku Co Ltd |
Compuesto heterocíclico condensado o su sal, insecticida agrícola u hortícola que comprende el comp uesto y método de uso del insecticida
|
US20140275108A1
(en)
|
2013-03-15 |
2014-09-18 |
Galderma Research & Development |
Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
|
JO3279B1
(ar)
|
2013-03-15 |
2018-09-16 |
Respivert Ltd |
مشتقات 2-((4- امينو -3- (3- فلورو-5- هيدروكسي فينيل)-h1- بيرازولو [d-3,4] بيرمدين-1-يل )ميثيل )- 3- (2- تراي فلورو ميثيل ) بينزيل ) كوينازولين -4 (h3)- واحد واستخدامها كمثبطات فوسفواينوسيتايد 3- كاينيز
|
TWI689489B
(zh)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
|
TWI689490B
(zh)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
用於治療纖維化之經取代之芳族化合物及相關方法
|
AU2014305989B2
(en)
|
2013-08-07 |
2019-11-28 |
Incyte Holdings Corporation |
Sustained release dosage forms for a JAK1 inhibitor
|
CA2921959A1
(en)
|
2013-08-23 |
2015-02-26 |
Incyte Corporation |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
|
SMT201800551T1
(it)
|
2014-02-28 |
2019-01-11 |
Incyte Corp |
Inibitori di jak1 per il trattamento di sindromi mielodisplastiche
|
HRP20201887T1
(hr)
|
2014-04-08 |
2021-02-05 |
Incyte Corporation |
LIJEČENJE B-STANIČNIH MALIGNITETA S KOMBINACIJOM INHIBITORA JAK i PI3K
|
CR20160553A
(es)
|
2014-04-30 |
2017-04-25 |
Incyte Corp |
Procesos para preparar un inhibidor de jak1 y nuevas formas de este
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
WO2016196244A1
(en)
|
2015-05-29 |
2016-12-08 |
Incyte Corporation |
Pyridineamine compounds useful as pim kinase inhibitors
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
WO2017059251A1
(en)
|
2015-10-02 |
2017-04-06 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|